EMILY WARRICK: Open Payments
NPI 1073126207 · CLEARFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 15 payments from 8 companies in 2025. Trend: 2023 $796 · 2024 $458 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 4 | $70 |
| ABBVIE INC. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Indivior Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| Medtronic, Inc. | 1 | $15 |
Products named: Belbuca, REXULTI, QULIPTA, SUBLOCADE, Auvelity, VOQUEZNA, Veozah, INCEPTIV.
Industry payments across PA — which companies pay providers there.
